Northwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below 200-Day Moving Average – Here’s Why

Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.39 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.29, with a volume of 1,782,919 shares traded.

Northwest Biotherapeutics Stock Up 4.8 %

The firm’s 50-day simple moving average is $0.31 and its 200-day simple moving average is $0.39. The firm has a market capitalization of $361.14 million, a PE ratio of -4.19 and a beta of -0.58.

Northwest Biotherapeutics (OTCMKTS:NWBO) last posted its quarterly earnings results on Friday, August 9th. The biotechnology company reported ($0.02) EPS for the quarter. The company had revenue of $0.51 million for the quarter.

About Northwest Biotherapeutics

Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.